|
 |
Richard
Anderson, CEO, De Facto Communications
Richard is CEO of De Facto Communications and a co-founder of the
Company. With over 20 years of medical marketing experience he has
a unique breadth and depth of experience in international communications
with patients and physicians.
In addition to his corporate role, Richard has specific responsibility
for De Facto’s patient recruitment and retention services. He
has led the Company to become the fastest growing business of its
kind in Europe working with top 10 pharmaceutical companies and many
leading CROs on international clinical studies.
In 2004 De Facto formed a global strategic alliance with MediciGroup
(Philadelphia, USA) one of the world’s most successful recruitment
and retention businesses. With an increasing number of studies becoming
conducted on a global basis, De Facto and MediciGroup work seamlessly
on global projects on both sides of the Atlantic.
Richard holds a life science degree and is an active member of the
UK’s Pharmaceutical Marketing Society and BioIndustry Association
having spent much of his earlier career advising leading pharmaceutical
companies on their corporate and product brand reputations. |
|